Cecilia CabreraMar 25NewsDeepMirror Obtains ISO27001 Certification, Reinforcing Commitment to Data Security and PrivacyIn drug discovery, where intellectual property and confidential data are paramount, ensuring robust security measures is a top priority...
Cecilia CabreraMar 8Finding new active molecules 6x faster with DeepMirrorOptimising ADMET properties is an essential step in drug discovery to ensure new drugs are absorbed, reach the right place, are non-toxic...
Cecilia CabreraJan 29BlogpostOne AI to rule them all?Is there a single AI model that can accurately predict whether a molecule would be a good drug against a disease?
Cecilia CabreraDec 11, 2023NewsDeepMirror launches early access programme for its intuitive molecular drug design software Innovative product enables medicinal chemists to access and integrate AI to boost productivity and creativity, to accelerate therapeutic dru
Cecilia CabreraDec 6, 2023NewsDeepMirror has been awarded an Innovate UK Biomedical Catalyst grant in collaboration with NucleraDeepMirror has successfully secured UKRI’s Biomedical Catalyst grant in collaboration with Nuclera.
Cecilia CabreraOct 24, 2023BlogpostDiscovering potent and specific kinase inhibitors with the DeepMirror AppKinases are frequently dysregulated in disease and are an interesting yet challenging target against which to develop drugs. In this...
Cecilia CabreraSep 13, 2023BlogpostDeepMirror for mouse brain image annotationAutomatic image annotation tools for biomedical have emerged as a game-changer, simplifying the laborious task of analysing and...
Cecilia CabreraAug 29, 2023NewsDeepMirror has been awarded a UKRI grant in collaboration with BiologICDeepMirror has successfully secured UKRI’s Innovative technologies for nucleic acid medicines manufacturing grant in collaboration with Biol